Search for: "Initiative for Medicines, Access and Knowledge"
Results 21 - 40
of 341
Sort by Relevance
|
Sort by Date
5 Nov 2023, 3:10 pm
OCR initiated a compliance review of DADS on June 23, 2015 in response to the breach notification. [read post]
31 Oct 2023, 6:26 am
Pix Credit here My Administration places the highest urgency on governing the development and use of AI safely and responsibly, and is therefore advancing a coordinated, Federal Government-wide approach to doing so. [read post]
25 Oct 2023, 9:01 pm
Key takeaways Diagnosing the true reasons for the failure of Silicon Valley Bank (SVB) and the contagion it fostered is critical to prescribing the right medicine to reduce the risk of similar failures and contagion in the future. [read post]
23 Oct 2023, 7:39 am
· SB 1046 increases from a misdemeanor to a felony domestic abuse committed against a pregnant woman with knowledge of the pregnancy. [read post]
27 Sep 2023, 9:29 am
A few initial comments on this travesty of a lawsuit follow. [read post]
20 Sep 2023, 9:05 pm
Updating and reorganizing infant formula related materials on FDA.gov to provide both consumers and industry with more accessible information, including: Infant Formula Cronobacter sakazakii Initiating work with the National Advisory Committee on Microbiological Criteria for Foods (NACMCF) to address knowledge gaps regarding Cronobacter sakazakii. [read post]
10 Aug 2023, 7:13 am
That said, it is equally important that federal regulation not duplicate state regulation of the practice of medicine. [read post]
24 Jul 2023, 9:00 pm
You schedule a free initial consultation. [read post]
6 Jun 2023, 9:17 am
Access to Medical Experts: Proving medical malpractice often requires the testimony and analysis of medical experts who can evaluate your case and provide professional opinions. [read post]
24 May 2023, 5:16 pm
OCR’s investigation began after MedEvolve notified OCR of a breach of PHI’s on its server through an initial Breach Notification Report filed on July 10, 2018, which it supplemented by addendums filed on July 30, 2018 and August 12, 2020 (the “Reports”). [read post]
14 Mar 2023, 4:09 pm
While both duties apply regardless of technology area, the discussion supported USPTO initiatives pursuant to President Biden’s July 2021 Executive Order on “Promoting Competition in the American Economy” to “promote greater access to medicines for American families. [read post]
9 Mar 2023, 7:36 am
Benjamin Alarie and Abdi Aidid are legal experts who are heavily involved in the development of legal technology. [read post]
7 Feb 2023, 12:00 pm
Indeed, the panel’s ruling seems to suggest that HHS could not expressly add a requirement that pharmaceutical companies deliver to a reasonable number of contract pharmacies used by a covered entity to distribute medicines to patients. [read post]
2 Feb 2023, 1:58 pm
The key data being questioned is that of the Initiative for Medicines, Access & Knowledge (I-MAK), an advocacy organization that has become a “principal, go-to source” for data on the number of patents and patent applications covering pharmaceutical innovations. [read post]
2 Feb 2023, 1:58 pm
The key data being questioned is that of the Initiative for Medicines, Access & Knowledge (I-MAK), an advocacy organization that has become a “principal, go-to source” for data on the number of patents and patent applications covering pharmaceutical innovations. [read post]
1 Feb 2023, 8:11 am
Further, a creative work’s copyrightability limits the expression of an idea.[13]Therefore, under the scope set forth by the Copyright Act, the eligibility for copyright or copyrightability of TK/TCE has three-tiers[14]: 1) whether indigenous artists/artisans have the claim of their authorship matches the Copyright Act; 2) whether TK/TCE is based initially on the Copyright Act’s definition; and 3) whether TK/TCE is fixed in a tangible medium to be copyrightable. [read post]
30 Jan 2023, 1:17 pm
Mossoff highlighted discrepancies between patent-per-drug numbers reported by Initiative for Medicines, Access & Knowledge (I-MAK), and the number of patents listed in the Orange Book or asserted in patent litigation for a given drug. [read post]
4 Jan 2023, 2:22 am
For example, for early phase clinical studies, assays should be in place to access identity, quality, strength, and purity. [read post]
3 Jan 2023, 1:45 pm
The attack was motivated by a now largely discredited disinformation campaign by the advocacy group I-MAK (Initiative for Medicines, Access and Knowledge; an oxymoron), based on non-peer reviewed erroneous patent data analysis (see supporting false analyses by Univ. of Calif. [read post]
3 Jan 2023, 1:45 pm
The attack was motivated by a now largely discredited disinformation campaign by the advocacy group I-MAK (Initiative for Medicines, Access and Knowledge; an oxymoron), based on non-peer reviewed erroneous patent data analysis (see supporting false analyses by Univ. of Calif. [read post]
